Not blinding sampling times [Bioanalytics]

posted by Obinoscopy  – USA, 2018-08-20 00:20 (1866 d 19:07 ago) – Posting: # 19177
Views: 3,240

Hi Helmut,

❝ Even if substantial carry-over is not apparent in method validation (which would call for injecting mobile phase between samples), it exists. The EMA’s GL tells us [...]



Going by that guideline, will it be safe to say that the converse it also true. That is:

If it appears there is no carry-over, study samples should be randomised


Well, just as you said, carryover is always very likely. Thus complete randomisation will not be the reasonable path to follow.

Thanks guys, at least I am glad I let my thoughts out and not get drowned in them.

Scopy

Complete thread:

UA Flag
Activity
 Admin contact
22,763 posts in 4,775 threads, 1,627 registered users;
12 visitors (0 registered, 12 guests [including 5 identified bots]).
Forum time: 19:28 CEST (Europe/Vienna)

A little Learning is a dang’rous Thing;
Drink deep, or taste not the Pierian Spring:
There shallow Draughts intoxicate the Brain,
And drinking largely sobers us again.    Alexander Pope

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5